Product Offerings
Products:
Therapeutic Drugs: Antibiotics, Antihistamines, Cardiovascular, Antidiabetics
Herbal and Nutraceuticals: Herbal Supplements, Vitamins, Dietary Supplements
Veterinary Products: Animal Health Solutions, Pesticides
Square Pharmaceuticals Ltd. is the largest and most respected pharmaceutical company in Bangladesh, with a legacy of over six decades in manufacturing, innovation, and international expansion. Founded in 1958 and headquartered in Dhaka, Square has grown into a vertically integrated pharmaceutical powerhouse, renowned for its commitment to quality, sustainability, and healthcare accessibility both domestically and globally.
Core Business
Square Pharmaceuticals is engaged in the research, development, manufacturing, and marketing of a broad spectrum of pharmaceutical products across human, herbal, nutraceutical, and veterinary segments. The company operates under the highest global regulatory standards and is a pioneer in exporting Bangladeshi pharmaceutical products to regulated and semi-regulated markets worldwide.
Product and Service Offerings
Human Pharmaceuticals
- Antibiotics and Anti-infectives
- Cardiovascular Medications
- Antidiabetics
- Analgesics and Anti-inflammatory Drugs
- Gastrointestinal, Respiratory, and CNS Medications
- Nutraceuticals and Dietary Supplements
Herbal and Nutraceuticals
- Herbal Supplements developed using traditional medicinal knowledge and modern extraction techniques
- Vitamins and Minerals under strict quality assurance
- Immunity Boosters including formulations using turmeric, tulsi, and ginger
Veterinary Products
- Animal Health Formulations for poultry, cattle, and aquaculture
- Nutritional Premixes
- Anthelmintics, Antibiotics, and Pesticides
The company also produces lifestyle and hygiene products under brands such as Senora (sanitary napkins) and Sepnil (disinfectants and sanitizers).
Specialization and Unique Selling Proposition
Square Pharmaceuticals stands out due to:
- WHO-cGMP, UK MHRA, TGA Australia, and EU-GMP certified facilities
- Robust R&D investment exceeding USD 10 million annually
- Broad therapeutic coverage with over 700 pharmaceutical products
- Automation and digitization across its production and distribution lines
- Market-leading quality assurance and pharmacovigilance systems
Square was the first Bangladeshi company to export pharmaceuticals to the UK, Australia, and Kenya, setting benchmarks for quality compliance.
Financials and Business Strength
Square Pharmaceuticals is publicly listed and financially robust:
- Revenue FY 2022-2023: BDT 69.58 billion (~USD 634 million)
- Net Profit: BDT 16.09 billion (~USD 147 million)
- Export Revenue: BDT 2.33 billion (~USD 21 million), with year-over-year growth exceeding 15%
- Market Capitalization: One of the top 5 listed companies on the Dhaka Stock Exchange
The company has maintained double-digit revenue and profit growth for over a decade, supported by innovation, exports, and domestic demand.
International Reach and Shipments
Square Pharmaceuticals exports to over 45 countries, including:
- Regulated Markets: UK, Australia, Kenya, Myanmar
- Semi-regulated and Emerging Markets: Vietnam, the Philippines, Sri Lanka, Ghana, Sudan, Nigeria
Key export categories include antibiotics, cardiovascular, anti-diabetics, and herbal nutraceuticals. Square’s manufacturing facilities are audited and approved by health authorities in UK, Kenya, Tanzania, Ethiopia, Yemen, and the Philippines.
Target Market
Square’s products serve:
- Hospitals and clinics
- Retail pharmacies and wholesale distributors
- Government and NGO-led health programs
- Veterinary professionals and livestock integrators
- Herbal and wellness practitioners
- Institutional buyers and donor-funded agencies
Their integrated supply chain allows high-volume delivery to both public and private healthcare sectors.
Capabilities
- 11 manufacturing units in Bangladesh and Kenya, including state-of-the-art formulation, injectable, and API plants
- Central Quality Control Laboratory with HPLC, GC, FTIR, and dissolution systems
- Advanced ERP and supply chain platforms
- In-house R&D lab with pre-clinical and clinical research capabilities
- Training academy for continuous development of pharmacists and plant operators
Certifications and Compliance
Square Pharmaceuticals maintains a world-class regulatory framework:
- UK MHRA (United Kingdom)
- TGA Australia
- WHO-cGMP
- EU-GMP
- ISO 9001:2015 and ISO 14001:2015
- Bangladesh Directorate General of Drug Administration (DGDA) certified
These certifications enable Square to compete with global pharma giants in tender and private markets alike.
Customer Testimonials
“Square has become our go-to partner for high-quality generics. Their regulatory documentation and product consistency are excellent.”
— Procurement Head, Government Tender, East Africa
“The herbal range is a game-changer for our wellness product line. Safe, effective, and well-packaged.”
— CEO, Regional Pharmaceutical Distributor, Southeast Asia
Major Achievements
- First Bangladeshi company to export to UK and Australia
- Winner of ICMAB Best Corporate Award (multiple years)
- Named Top Pharmaceutical Exporter of Bangladesh by EPB
- Commissioned a new API Plant (API Park Project) for vertical integration
- Successfully launched Square Lifesciences Ltd., a healthcare subsidiary focused on biologics and next-generation therapies
Square Pharmaceuticals Ltd. continues to set the benchmark for pharmaceutical manufacturing in Bangladesh and beyond. With a blend of innovation, regulatory strength, and unwavering commitment to public health, it is shaping the future of accessible and sustainable healthcare in developing and developed markets alike.